Order Article Reprints

Kandeil A, Mostafa A, Hegazy RR, El-Shesheny R, El Taweel A, Gomaa MR, Shehata M, Elbaset MA, Kayed AE, Mahmoud SH, et al. Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines. 2021; 9(3):214. https://doi.org/10.3390/vaccines9030214

Kandeil, Ahmed, Ahmed Mostafa, Rehab R. Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Mahmoud Shehata, Marawan A. Elbaset, Ahmed E. Kayed, Sara H. Mahmoud, and et al. 2021. "Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies" Vaccines 9, no. 3: 214. https://doi.org/10.3390/vaccines9030214

Kandeil, A., Mostafa, A., Hegazy, R. R., El-Shesheny, R., El Taweel, A., Gomaa, M. R., Shehata, M., Elbaset, M. A., Kayed, A. E., Mahmoud, S. H., Moatasim, Y., Kutkat, O., Yassen, N. N., Shabana, M. E., GabAllah, M., Kamel, M. N., Abo Shama, N. M., El Sayes, M., Ahmed, A. N., ... Ali, M. A. (2021). Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines, 9(3), 214. https://doi.org/10.3390/vaccines9030214